1. Inicio
  2. Proyectos y Estudios
  3. “Retrospective, Observational Study on The Efficacy And Safety of Lorlatinib In ALK or ROS1 Metastatic Non-Small Cell Lung Cancer Patients Treated Within The Compassionate Use Program In Spain” LORLAPULM Study .

“Retrospective, Observational Study on The Efficacy And Safety of Lorlatinib In ALK or ROS1 Metastatic Non-Small Cell Lung Cancer Patients Treated Within The Compassionate Use Program In Spain” LORLAPULM Study .

Datos básicos

ESTUDIO OBSERVACIONAL GECP 21/04 HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2022 Año de finalización: 2023

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

FUNDACIÓN GECP

Cita

Compartir